StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Trading Down 92.0 %
NASDAQ CALA opened at $0.00 on Friday. The business’s 50-day moving average price is $0.02 and its 200 day moving average price is $0.02. Calithera Biosciences has a twelve month low of $0.00 and a twelve month high of $0.13.
Calithera Biosciences Company Profile
Further Reading
- Five stocks we like better than Calithera Biosciences
- How to Calculate Inflation Rate
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- 3 Monster Growth Stocks to Buy Now
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
